Inadequate Glycaemic Control

Drug	Drug Name	Drug Description
DB00222	Glimepiride	A sulfonylurea drug used to treat type 2 diabetes mellitus.
DB01307	Insulin detemir	A long-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus.

Drug	Drug Name	Target	Type
DB00222	Glimepiride	ATP-sensitive inward rectifier potassium channel 1	target
DB00222	Glimepiride	ATP-sensitive inward rectifier potassium channel 11	target
DB00222	Glimepiride	Cytochrome P450 2C9	enzyme
DB00222	Glimepiride	ATP-binding cassette sub-family C member 8	target
DB00222	Glimepiride	Bile salt export pump	transporter
DB01307	Insulin detemir	Insulin receptor	target
DB01307	Insulin detemir	Serum albumin	carrier
DB01307	Insulin detemir	Insulin-like growth factor 1 receptor	target
DB01307	Insulin detemir	Cytochrome P450 1A2	enzyme
DB01307	Insulin detemir	Insulin-degrading enzyme	enzyme

Drug	Drug Name	Phase	Status	Count
DB06292	Dapagliflozin	3	Completed	4
DB06335	Saxagliptin	3	Completed	1
DB06292	Dapagliflozin	4	Completed	1
DB00222	Glimepiride	4	Completed	1
DB06335	Saxagliptin	4	Completed	1